Semaglutide and liraglutide are associated with a reduced risk for hospitalization due to alcohol use disorder (AUD).

COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among adults so far this respiratory virus season (2024 to 2025).

Digital health tools have the potential to improve health outcomes among individuals with IBS, but more research is needed.

Mortality risk, especially due to dermatological and endocrine causes, was higher among patients with type 1 diabetes compared with type 2 diabetes.

Younger and middle-aged patients seem to be disproportionately affected by neurologic manifestations of postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection (Neuro-PASC).

An estimated 100,429 youth are living with pediatric inflammatory bowel disease (PIBD) in the United States, according to a research letter.

AI for IBD is gradually improving clinical care for gastroenterologists, but it comes with challenges, such as cost and ...

Asian American, Native Hawaiian, and Pacific Islander (AANHPI) patients with early-stage hepatocellular carcinoma (HCC) have significantly better survival outcomes compared with non-Hispanic White ...

Placebo rates in induction and maintenance trials for Crohn disease (CD) were generally increased for clinical response compared with clinical remission, according to a study in Gastroenterology.

Fidaxomicin use in the treatment of CDI has significantly increased since the IDSA 2021 Clinical Guideline Update; however, its use is still low.

An abnormally large colon among individuals with IBS-C and functional constipation could help predict impaired manometric response.

There is a statistically significant association between small bowel disease on imaging and patency capsule and VCE retention.